U.S. Implantable and Interventional Cardiovascular Device Markets

Increase Competition Within a $1.86 Billion Industry
  • 1 Pages
  • 0.78 MB
  • English
Frost & Sullivan
Cardiology, Medical / Nu
The Physical Object
ID Numbers
Open LibraryOL8151681M
ISBN 100788901303
ISBN 139780788901300

This statistic shows the value of the cardiovascular devices market in the U.S. in andwith a forecast forby category. Inthe total value of the cardiovascular devices. New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with the use of innovative materials and new technologies.

While new concepts for cardiac technology are not lacking, successful commercialization is a skill that is also required. Business analysts from the healthcare market research firm Allied Market Research.

Implantable cardioverter defibrillator (ICD) or automated implantable cardioverter defibrillators can save patients from arrhythmias by regulating the irregular heartbeats.

The device is used in treating sudden cardiac arrest caused due to cardiac arrhythmias, particularly ventricular fibrillation and pulseless ventricular tachycardia.

The global interventional cardiology devices market is expected to reach USD Billion by from USD Billion inat a CAGR of %. Market growth is primarily driven by the growing incidence of CVD and technological advancements in interventional cardiology devices.

Aims. Complications after cardiac implantable electronic device (CIED) treatment, including permanent pacemakers (PMs), cardiac resynchronization therapy devices with defibrillators (CRT-Ds) or without (CRT-Ps), and implantable cardioverter defibrillators (ICDs), are associated with increased patient morbidity, healthcare costs, and possibly increased by: The interventional cardiology market includes, but is not limited to, drug-eluting stents, bare-metal stents, percutaneous transluminal coronary angioplasty (PTCA) and cutting balloon catheters.

Although this market is growing overall, some segments are experiencing low negative growth and even dropping in value. Currently there are a few top competitors that hope to gain market. The U.S. implantable medical devices market features a fair degree of consolidation with a handful of companies enjoying dominance in this market, says the lead author of the study.

Download U.S. Implantable and Interventional Cardiovascular Device Markets PDF

Some of these companies are Zimmer Holdings, Stryker Corporation, and Abbott Laboratories. A TMR analyst points out, “Making investments in emerging markets is a primary strategy adopted by key players in the U.S. Global cardiovascular devices market size expected to generate revenue of around USD billion bygrowing at CAGR of around % between and Cardiovascular disease is one of the prominent causes of death among Western countries across the globe.

Implantable Medical Devices Market Report, forecasts that the global market is expected to garner $, million byregistering a CAGR of % during the period North America accounted for nearly half of the global market share inand is projected to maintain its dominance during the forecast period.

According to a new market report published by Transparency Market Research "Implantable Medical Devices Market (Reconstructive Joint Replacement, Spinal Implan. Sources included companies in the cardiovascular device market and supply industry, public documents, SEC filings, corporate white papers and other technical documentation for U.S.

and. Mortality and cost associated with cardiovascular implantable electronic device infections.

Details U.S. Implantable and Interventional Cardiovascular Device Markets EPUB

Sohail MR(1), Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Author information: (1)Division of Infectious Diseases, Mayo Clinic College of Medicine, First Street SW, Rochester, MNUSA.

[email protected] by:   Cardiovascular implants: A cardiovascular implant is a manufactured device that enables proper and assisted functioning of the heart and its c implantable devices include pacemakers, stents, cannulae, and catheters.

Some of the common cardiovascular implant surgeries are cardiac resynchronization therapy which places a small. Dublin, Jan. 24, (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Implantable Medical Devices Market Analysis and Trends - Product, Material - Forecast to Author: Research And Markets.

$ Billion Cardiovascular Surgical Devices Technologies and Global Markets Email Print Friendly Share Ap ET | Source: Research and MarketsAuthor: Research And Markets.

The global cardiovascular devices market has been segmented into diagnostic & monitoring devices and surgical devices. The diagnostic and monitoring device segment is further segmented into ECG, Holter monitors, event monitors, implantable loop recorders, echocardiograms, PET scans, MRI, cardiac CT, and doppler fetal monitors.

The report on cardiovascular implants market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global.

Description U.S. Implantable and Interventional Cardiovascular Device Markets PDF

Access up-to-date Cardiovascular Devices market research reports, complete with concise analysis and forecasts for global and regional markets.

EAST COAST U.S. U.S. (TOLL FREE) The cardiovascular device sector is therefore recession-proof to a large degree, and will experience growth for the foreseeable future. Similar to other medical device markets, the interventional cardiology market been experiencing a period of consolidation in recent years.

Large competitors are either entering the overall market or expanding their reach by entering new segments through strategic mergers and acquisitions. The global cardiovascular device market looks good with opportunities in public and private hospitals.

The global cardiovascular device market is expected to reach an estimated $ billion byand it is forecast to grow at a CAGR of % from to The major drivers for market growth are growing demand for minimally.

Compared with an open-heart procedure, treatment with an AGA Medical device typically reduces patient trauma, shortens hospital stay and recovery time, and lowers overall treatment costs. Founded in by Dr Kurt Amplatz, a former University of Minnesota radiology professor and a pioneer in the field of interventional radiology, AGA Medical.

The global implantable heart pacemaker market is segmented based on product type, end user/applications, and geography. Based on product type, the market is divided into single chamber, dual chamber, and biventricular pacemaking.

The Global Cardiovascular Surgical Devices Market is poised to grow at a CAGR of around % over the next decade to reach approximately $. On the basis of product, the cardiovascular devices market has been categorized into cardiovascular monitoring and diagnostic devices, coronary stents, pacemakers, defibrillators, interventional cardiac devices, heart valves, cardiac ablation catheters, ventricular assist devices, and other devices.

Inthe U.S. market for interventional cardiology devices was valued at over $ billion, a moderate increase from The interventional cardiology market includes: drug-eluting stents. Global cardiovascular devices market is anticipated to reach USD billion byaccording to a new report by Grand View Research, Inc.

Increasing geriatric population, sedentary life style coupled with unhealthy dietary habits is spurring the prevalence of cardiovascular diseases. Constant rise in the patients suffering from cardiovascular diseases and is expected to drive.

Implantable Cardioverter Defibrillator Market. Implantable Cardioverter Defibrillator market study with market size, share, valuation, segment-wise analysis, competitive landscape analysis, regulatory framework analysis and impact of Covid Outbreak on Implantable Cardioverter Defibrillator industry/5(38).

The future of the interventional cardiology and peripheral vascular device market looks promising with opportunities in hospitals and ambulatory surgical centers. The interventional cardiology and peripheral vascular device market is expected to reach an estimated $ billion byand it is forecast to grow at a CAGR of % from to.

The medical device market was about $ billion last year and is projected to hit $ billion by Drug delivery devices, one of the segments, reached $ billion in and is projected to hit $ billion inwhile cardiovascular devices were $ billion last year projected to rake in $ billion in The global cardiac bio-implant devices market is segmented into structural cardiac implants, stents and related implants, a pacing device, disease conditions, and procedures.

The structural cardiac implants segment comprises ventricular-assist devices, heart valves, and accessories, insertable loop recorders/implantable heart monitors.

( via COMTEX) -- The new research from on Global Implantable Drug Delivery Devices Market Report for   Cardiovascular Surgical Devices: Technologies and Global Markets - The global market for cardiovascular surgical devices used in the operating room is worth an estimated $31 billion in Bythis market will be valued at nearly $48 billion, a compound annual growth rate (CAGR) of %.

U.S. utilization of AICD implantable medical devices U.S. utilization of CRT-D implantable medical devices U.S. utilization of knee replacement implantable medical devices